Search Result

Results for "

CaMK

" in MCE Product Catalog:

By Targets:	CaMK (10) Autophagy (5) EGFR (1) P2X Receptor (1) Pim (1) SphK (2) Src (3)
By Research Areas:	Cancer (9) Metabolic Disease (1) Neurological Disease (7)

Inhibitors & Agonists

Peptides

Recombinant Proteins

Antibodies

Targets Recommended: CaMK

Cat. No.	Product Name	Target	Research Areas

HY-13290

KN-62	CaMK P2X Receptor	Metabolic Disease Cancer
KN-62 is a selective and reversible inhibitor of calmodulin-dependent protein kinase II (CaMK-II) with a K_i of 0.9 μM for rat brain CaMK-II. KN-62 directly binds to the calmodulin binding site of CaMK-II. KN-62 displays noncompetitive antagonism at P2X₇ receptors in HEK293 cells, with an IC₅₀ value of approximately 15 nM.

HY-P1528

Autocamtide 2, amide
CaMK Autophagy Neurological Disease

Autocamtide 2, amide is a substrate (100 μM final concentration) for CaMK family assays.
HY-15465B

KN-93 phosphate
CaMK Autophagy Cancer

KN-93 phosphate is a novel membrane-permeant synthetic inhibitor of purified neuronal CaMK-II, with K_i of 370 nM.

Autocamtide 2, amide	CaMK Autophagy	Neurological Disease
Autocamtide 2, amide is a substrate (100 μM final concentration) for *CaMK* family assays.

KN-93 phosphate	CaMK Autophagy	Cancer
KN-93 phosphate is a novel membrane-permeant synthetic inhibitor of purified neuronal *CaMK-II*, with K_i of 370 nM.

HY-103319

Calmidazolium chloride R 24571	CaMK Autophagy	Cancer Neurological Disease
Calmidazolium chloride (R 24571) is a calmodulin (CaMK) antagonist, antagonizing CaM-dependent phosphodiesterase and calmodulin-induced activation of erythrocyte Ca2+-transporting ATPase with IC₅₀s of 0.15 and 0.35 μM, respectively. Also in anti-cancer research. Calmidazolium binds to CaMK with a K_d of 3 nM.

HY-143898

PIM1-IN-4	Pim	Cancer
PIM1-IN-4 (Compound 8) is a potent inhibitor of PIM1. PIM1-IN-4 reveals strong inhibition of five other enzymes, i.e., SGK-1, PKA, CaMK-1, GSK3β, and MSK1. PIM1-IN-4 has the potential for the research of cancer diseases.

HY-P3811

Autocamtide-3
CaMK Neurological Disease

Autocamtide-3, a 13-amino-acid peptide containing Thr287, is a selective CaMKII (Ca²⁺/calmodulin-dependent kinase II) (CaMK) substrate.

Autocamtide-3	CaMK	Neurological Disease
Autocamtide-3, a 13-amino-acid peptide containing Thr287, is a selective CaMKII (Ca²⁺/calmodulin-dependent kinase II) (CaMK) substrate.

HY-P1479

Calmodulin-Dependent Protein Kinase II (290-309)	Autophagy CaMK	Neurological Disease
Calmodulin-Dependent Protein Kinase II (290-309) is a potent *CaMK* antagonist with an IC₅₀ of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II.

HY-P1479A

Calmodulin-Dependent Protein Kinase II(290-309) acetate	Autophagy CaMK	Neurological Disease
Calmodulin-Dependent Protein Kinase II (290-309) acetate is a potent *CaMK* antagonist with an IC₅₀ of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II.

HY-P3944

Calmodulin Dependent Protein Kinase Substrate	CaMK	Neurological Disease
Calmodulin Dependent Protein Kinase Substrate is a Ca²⁺- and calmodulin (CaM)-dependent protein kinase (CaMK) substrate peptide. Calmodulin Dependent Protein Kinase Substrate is a synthetic peptide substrate for protein kinases.

HY-P3943

Calmodulin Dependent Protein Kinase Substrate Analog	CaMK	Neurological Disease
Calmodulin Dependent Protein Kinase Substrate Analog is a Ca²⁺- and calmodulin (CaM)-dependent protein kinase (CaMK) substrate peptide. Calmodulin Dependent Protein Kinase Substrate Analog is a synthetic peptide substrate for protein kinases.

HY-W013857

Lavendustin C	CaMK EGFR Src	Cancer
Lavendustin C is a potent *Ca²⁺ calmodulin-dependent kinase II (CaMK* II) inhibitor with an IC₅₀ of 0.2 µM. Lavendustin C inhibits EGFR-associated tyrosine kinase (IC₅₀=0.012 µM) and pp60^c-src(+) kinase (IC₅₀**=0.5 µM) .

HY-13941B

1-Naphthyl PP1 hydrochloride 1-NA-PP 1 hydrochloride	Src	Cancer
1-Naphthyl PP1 hydrochloride (1-NA-PP 1 hydrochloride) is a selective inhibitor of src family kinases. 1-Naphthyl PP1 hydrochloride inhibits v-Src and c-Fyn, c-Abl, CDK2 and CAMK II with IC₅₀s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively.

HY-13941

1-Naphthyl PP1 1-NA-PP 1	Src	Cancer
1-Naphthyl PP1 (1-NA-PP 1) is a selective inhibitor of src family kinases. 1-Naphthyl PP1 inhibits v-Src and c-Fyn, c-Abl, CDK2 and CAMK II with IC₅₀s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively.

HY-119016A

SK1-I hydrochloride BML-258 hydrochloride	SphK	Cancer
SK1-I hydrochloride (BML-258 hydrochloride), an analog of sphingosine, is an isozyme-specific competitive SPHK1 inhibitor with a K_i value of 10 µM. SK1-I hydrochloride shows no activity at SPHK1 PKCα, PKCδ, PKA, AKT1, ERK1, EGFR, CDK2, IKKβ or CamK2β. SK1-I hydrochloride enhances autophagy and has antitumor activity.

HY-119016

SK1-I BML-258	SphK	Cancer
SK1-I (BML-258), an analog of sphingosine, is an isozyme-specific competitive SPHK1 inhibitor with a K_i value of 10 µM. SK1-I shows no activity at SPHK1 PKCα, PKCδ, PKA, AKT1, ERK1, EGFR, CDK2, IKKβ or CamK2β. SK1-I enhances autophagy and has antitumor activity.

Cat. No.	Product Name	Target	Research Area

HY-P1528

Autocamtide 2, amide
CaMK Autophagy Neurological Disease

Autocamtide 2, amide is a substrate (100 μM final concentration) for CaMK family assays.
HY-P3811

Autocamtide-3
CaMK Neurological Disease

Autocamtide-3, a 13-amino-acid peptide containing Thr287, is a selective CaMKII (Ca²⁺/calmodulin-dependent kinase II) (CaMK) substrate.

Autocamtide 2, amide	CaMK Autophagy	Neurological Disease
Autocamtide 2, amide is a substrate (100 μM final concentration) for *CaMK* family assays.

Autocamtide-3	CaMK	Neurological Disease
Autocamtide-3, a 13-amino-acid peptide containing Thr287, is a selective CaMKII (Ca²⁺/calmodulin-dependent kinase II) (CaMK) substrate.

HY-P1479

Calmodulin-Dependent Protein Kinase II (290-309)	Autophagy CaMK	Neurological Disease
Calmodulin-Dependent Protein Kinase II (290-309) is a potent *CaMK* antagonist with an IC₅₀ of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II.

HY-P1479A

Calmodulin-Dependent Protein Kinase II(290-309) acetate	Autophagy CaMK	Neurological Disease
Calmodulin-Dependent Protein Kinase II (290-309) acetate is a potent *CaMK* antagonist with an IC₅₀ of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II.

HY-P3944

Calmodulin Dependent Protein Kinase Substrate	CaMK	Neurological Disease
Calmodulin Dependent Protein Kinase Substrate is a Ca²⁺- and calmodulin (CaM)-dependent protein kinase (CaMK) substrate peptide. Calmodulin Dependent Protein Kinase Substrate is a synthetic peptide substrate for protein kinases.

HY-P3943

Calmodulin Dependent Protein Kinase Substrate Analog	CaMK	Neurological Disease
Calmodulin Dependent Protein Kinase Substrate Analog is a Ca²⁺- and calmodulin (CaM)-dependent protein kinase (CaMK) substrate peptide. Calmodulin Dependent Protein Kinase Substrate Analog is a synthetic peptide substrate for protein kinases.

Species:	Human (6) Mouse (2) Rat (1)
Tag:	His (5) Tag Free (1) GST (6)
Source:	HEK293 (2) Sf9 insect cells (5) E. coli (2)

Cat. No.	Product Name	Species	Source

HY-P75457

CAMKIV/CAMK4 Protein, Mouse (sf9)
Calcium/calmodulin-dependent protein kinase type IV; CaMK IV; CaMK4; CaMK; CaMK-GR
Mouse Sf9 insect cells
HY-P75458

CAMKIV/CAMK4 Protein, Human (HEK293, GST)
Calcium/calmodulin-dependent protein kinase type IV; CaMK IV; CaMK4; CaMK; CaMK-GR
Human HEK293
HY-P75456

CAMKIV/CAMK4 Protein, Mouse (sf9, His-GST)
Calcium/calmodulin-dependent protein kinase type IV; CaMK IV; CaMK4; CaMK; CaMK-GR
Mouse Sf9 insect cells
HY-P700579

CAMKIV/CAMK4 Protein, Rat (His)
CaM kinase-GR; Calspermin
Rat E. coli

HY-P7714

CAMK1 Protein, Human (HEK293, His) rHuCaMK1, His; Calcium/Calmodulin-Dependent Protein Kinase Type 1; CaM Kinase I; CaMKI-Alpha; CaMK1	Human	HEK293
CAMK1 Protein, Human (HEK293, His), a recombinant human CAMK1 produced in HEK293 cells, has a His tag at the N-terminus. CAMK1 is involved in multiple cell functions, including calmodulin binding, ATP binding, signal transduction, development and cell differentiation.

HY-P7715

CAMK1 delta Protein, Human (GST) rHuCaMK1D, N-GST; Calcium/calmodulin-dependent protein kinase type 1D; CaMKI-like protein kinase; CaMK1D;	Human	E. coli
CAMK1 delta Protein, Human (GST), a recombinant human CAMK1D expressed in E. coli, has a GST tag at the N-terminus. CAMK1D acts as a key modulator of tumor-intrinsic immune resistance.

HY-P76762

CaMKII beta/CAMK2B Protein, Human (sf9, His-GST)
Calcium/calmodulin-dependent protein kinase type II subunit beta; CAM2; CaMK2; CaMKB
Human Sf9 insect cells
HY-P76761

CaMKII alpha/CAMK2A Protein, Human (sf9, GST)
Calcium/calmodulin-dependent protein kinase type II subunit alpha; CaMKA
Human Sf9 insect cells
HY-P76191

CAMKI gamma/CAMK1G Protein, Human (sf9, His-GST)
Calcium/calmodulin-dependent protein kinase type 1G; CaMKI gamma; CLICK III; CLICK3; VWS1
Human Sf9 insect cells

Cat. No.	Product Name	Application	Reactivity

HY-P80580

CaMK1 Rabbit mAb
CaM K1; CaM KI; CaMK 1; CaMK I; CaMK1 alpha; CaMK1 PEN; CaMKI alpha
WB Mouse, Rat

Rabbit Monoclonal Antibody to CaMK1

Name
Email *

	Sorry, but the email address you supplied was invalid.